Surgeons and physicians from across the U.S. and around the world came together to learn about PIPAC, an innovative therapy that delivers chemotherapy directly to tumors within the abdominal cavity. By targeting cancer at its source, PIPAC offers a new option for patients with limited treatment choices. This marks the third time the U.S. PIPAC Collaborative Group has united to train teams, advance research, and safely expand access to this emerging therapy. Everything we do is driven by one goal